Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2003
08/21/2003WO2002064776A3 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002062755A3 Polyamide analogs as dna minor groove binders
08/21/2003WO2002061090A3 Prokaryotically produced antibodies and uses thereof
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002056022A3 Diagnostics, drug screening and treatment for cancer
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044418A3 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002020463A3 Fxr modulators
08/21/2003WO2002004009A3 Method for treating cancer using an interleukin- 4 antagonist
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001080870A3 Compositions derived from cranberry and grapefruit and therapeutic uses therefor
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003US20030158413 A thiochromane-7-carboxamide derivatives as Rho kinase enzyme inhibitor; nontoxic, anticancer agents
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/21/2003US20030158390 Protein; Escherichia culture product; genetic engineering; fusion
08/21/2003US20030158388 MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof
08/21/2003US20030158249 Is significantly more active against hepatocellular carcinoma cells than paclitaxel at concentrations of up to 1 mu M.
08/21/2003US20030158243 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
08/21/2003US20030158241 Used for treatment of diabetes and a complication thereof, hyperlipidemia and a complication thereof, hyperuricemia, leukemia, and pancreatitis.
08/21/2003US20030158239 Reacting a selenourea and an alpha-haloacyl halide in a solvent and in the presence of a catalyst; useful as raw materials for drugs and agricultural chemicals
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158226 Treating or preventing emphysema, cancer and dermatological disorders
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158216 2-acyl indole derivatives and their use as antitumor agents
08/21/2003US20030158215 Tyrosine kinase inhibitors
08/21/2003US20030158212 E.g., 5-(3-pyridyl)-cyclohexothieno(2',3'-5,6)pyrimido-(3,4-a)-1,2,4- triazole; intracellular signal transduction; treating glioblastomas and juvenile myelomonocytic leukemia.
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158189 Non-steroidal antiinflammatory agents treating bone disorders, Crohn's disease, and inflammatory bowel disease, respiratory disorders such as chronic obstructive pulmonary disease, infections, autoimmune diseases
08/21/2003US20030158187 Genetic polymorphisms in the preprotachy kinin gene
08/21/2003US20030158182 Cyanopyrroles
08/21/2003US20030158178 Heterocyclic retinoid compounds
08/21/2003US20030158168 Composition for combined use of aromatase inhibitors
08/21/2003US20030158166 Administration of an anticancer (7-alpha-9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl)-estra-1,3,5,-(10) triene-3,17-diol to a breast cancer patient previously treated with an aromatase inhibitor and failed
08/21/2003US20030158164 Novel antiandrogenic agent
08/21/2003US20030158160 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
08/21/2003US20030158153 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/21/2003US20030158150 Combination therapy to treat hepatitis B virus
08/21/2003US20030158143 For treatment of endocrine-regulated tumors, for example, breast, prostate, ovarian and colon cancers
08/21/2003US20030158138 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide
08/21/2003US20030158127 Aromatic sulfenates for type I phototherapy
08/21/2003US20030158125 Polysaccharidic esters of n-derivatives of glutamic acid
08/21/2003US20030158123 Purified material having size and growth inhibitory effects on cells and tissues
08/21/2003US20030158110 Vasoactive intestinal peptide analogs
08/21/2003US20030158105 Determining polypeptide sequence of at least one Bcr-Abl polypeptide expressed by the human cancer cell and comparing the polypeptide sequence of the Bcr-Abl polypeptide expressed by the human cancer cell to the Bcr-Abl polypeptide sequence
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030157713 Anchorage-dependent cell for propagating and measuring cytotoxic activity of lymphocyte; antitumor agents
08/21/2003US20030157711 STAT3 activated stem cell
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157669 Ansamitocins
08/21/2003US20030157531 TAOJIKs as modifiers of the beta-catenin pathway and methods of use
08/21/2003US20030157502 Induce apoptosis; antitumor, anticancer agents
08/21/2003US20030157485 Forensic analysis; chromosome marking
08/21/2003US20030157482 Binding labeled antibody to protein; measurement; calibration
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157476 Immortalized human keratinocyte cell line
08/21/2003US20030157225 Food product and process
08/21/2003US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant
08/21/2003US20030157179 Use of magnetic particles
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157142 Implants with a phosphazene-containing coating
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157135 Enhancement and/or extension of antigen-specific Th1-type responses, in particular, CD8+ T cell responses; for treatment of various infectious and neoplastic diseases
08/21/2003US20030157128 Comprises exogenous nucleotide sequences which encode exogenous amino acid sequences; infection of host cell with recombinant Yellow Fever Virus provides for expression of exogenous nucleic acid and production of antigen
08/21/2003US20030157118 Tumour-specific animal proteins
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157104 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
08/21/2003US20030157101 Cytotoxic t-lymphocyte-epitopes from anaplastic lymphoma kinase (alk) protein; immunotherapy
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157098 Methods for inhibiting brain tumor growth
08/21/2003US20030157097 Novel remedies for cancer
08/21/2003US20030157095 Invasive and metastic ability of breast cancer cells is proportional to level of peripheral type benzodiazepine receptor expressed, correlates with subcellular localization in that it is found in the nucleus of aggressive tumor cells
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157082 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480,20893, 33230,1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
08/21/2003US20030157077 Induction of chimera mixture; anticancer agents, leukemia
08/21/2003US20030157065 Gene therapy; gene encoding drug metabolizing enzyme
08/21/2003US20030157059 Vaccine; infection therapy
08/21/2003US20030157055 Modified cytokines for use in cancer therapy
08/21/2003US20030157054 Recombinant tumor specific antibody and use thereof
08/21/2003US20030157052 Prodrug for in situ regeneration; water solubility
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003CA2513198A1 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003CA2476618A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003CA2476556A1 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2476366A1 Cancer therapy
08/21/2003CA2476282A1 Dosing regimen for gemcitabine hcv therapy
08/21/2003CA2476279A1 Modified fluorinated nucleoside analogues
08/21/2003CA2476162A1 Jnk inhibitor
1 ... 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 ... 2211